Remdesivir: First Approval

The antiviral agent remdesivir (Veklury®; Gilead Sciences), nucleotide analogue prodrug, has broad-spectrum activity against viruses from several families. Having demonstrated potent antiviral activity against coronaviruses in preclinical…

BASF PVP-Iodine

PVP-Iodine Skin and mucous membrane antisepsis as well as surgical and hand disinfection PVP-Iodine is an antiseptic that offers a broad spectrum of coverage, demonstrating antiviral, antibacterial, and antifungal activity. Found…

Friday’s Top 5 by pharmaexcipients

Another week full of great scientific publications - find the one you liked most! Top post of the last 30 days is still "How to improve API Bioavailability?"as you can also see in the Top post of 2020. Top posts of the week #1…

Nanotechnology-based antiviral therapeutics

The host immune system is highly compromised in case of viral infections and relapses are very common. The capacity of the virus to destroy the host cell by liberating its own DNA or RNA and replicating inside the host cell poses challenges…

Friday’s Top 5 by pharmaexcipients

Another week full of great scientific publications - find the one you liked most! Top posts of the week #1 Hot-Melt Extrusion – Enabling Technologies from Dupont #2 Tablet Quality-Prediction Model - Toward Flexible Switching Between…

Friday’s Top 5 by pharmaexcipients

The trending interest on how to improve API bioavailability goes on. The second week in a row the most viewed post on pharma excipients is now also ranking as the top post of the year. Let's see what is coming next! Top posts of the week…

Friday’s Top 5 by pharmaexcipients

You have you missed the most popluar articles of this week? No worries you will find them here. It seems that the reaction on the question "How to improve API Bioavailability" is a major concern in the industry and reflects the evolution in…